Company news

Quantum Cyber N.V. news in 2025

Quantum Cyber N.V.'s news releases, calls and decks from 2025, newest first.

View company

Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America

November 17, 2025

Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025

November 11, 2025

Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

October 7, 2025

Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland

September 22, 2025

Mainz Biomed Announces Registration of ColoAlert in the United Kingdom

September 1, 2025

Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®

August 12, 2025

Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants

August 3, 2025

Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies

July 22, 2025

Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition

July 14, 2025

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test

June 24, 2025

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

June 9, 2025

Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants

May 18, 2025

Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study

May 15, 2025

Mainz Biomed Enters into Technology Partnership with EDX Medical Group

April 28, 2025

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval

April 27, 2025

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update

March 31, 2025

Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study

March 26, 2025

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer

March 12, 2025

Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month

February 10, 2025

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements

January 26, 2025

Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population

January 20, 2025